Similarly, therapy with granulocyte colony stimulating factor (G-CSF) enhanced neurogenesis, improved working memory in the radial-arm maze test and in consequence the survival capacity and functional outcome after stroke [27]. The gene discussed is CSF3; the disease is stroke disorder.